KUAISHOU-W (01024) issued a total of 391,200 share options and 3,477,600 restricted share units.
Kuaishou-W (01024) announced that on April 17, 2026, the board of directors granted a total of 391,200 stock options and 3,477,600 restricted share units to company co-founder, executive director, CEO and major shareholder Mr. Cheng Yixiao under the 2023 share incentive plan, but they can only be exercised after accepted by the grantee.
KUAISHOU-W (01024) announced that on April 17, 2026, the board of directors granted a total of 391,200 stock options and 3,477,600 restricted share units to Mr. Cheng Yixiao, the co-founder, executive director, CEO, and major shareholder of the company, under the 2023 share incentive plan. However, the shares can only be transferred after acceptance by the grantee.
Related Articles
New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.
New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.
Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.
New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.
New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.
Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.
RECOMMEND
Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026
Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026
Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026
